AURKA overexpression contributed to oxaliplatin-induced death of colon cancer cells, while AURKA knockdown drastically reduced chemotherapy sensitivity of colon cancer cells to oxaliplatin. The gene discussed is AURKA; the disease is malignant colon neoplasm.